SonoSite expands GE patent lawsuit:
This article was originally published in Clinica
Executive Summary
Hand-carried ultrasound developer SonoSite has amended details of its ultrasound patent infringement countersuit against GE. The revised lawsuit now asserts that GE's Vivid and Logiq ultrasound products, certain transducers and the Vivid 7 cart-based system infringe two other patents '566 and '839 related to ultrasound technology with ECG modules and software in a detachable scanhead, in addition to the previous patents mentioned in the original complaint. SonoSite (Bothell, Washington) first filed its counterclaim in July this year in reaction to GE's lawsuit, which alleged that the former's MicroMaxx and Titan imaging systems contravened five patents related to technology that displays blood flow via ultrasound (see Clinica No 1264, p 15).
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.